Join
Live feed
·
INSIDERFilingvia Quantisnow
Salarius Pharmaceuticals Inc. logo

SEC Form 4: Burleson Tess bought $4,986 worth of shares (27,700 units at $0.18), increasing direct ownership by 637% to 32,050 units

ByQuantisnow·Wall Street's wire, on your screen.
SLRX· Salarius Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLRX (Salarius Pharmaceuticals Inc.) and more on Quantisnow.